Recursion (NASDAQ: RXRX) to Acquire Smaller Peer Exscientia in $688 Million Deal
NEW YORK – Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech firm that uses artificial intelligence to discover new drug candidates, has […]
Recursion (NASDAQ: RXRX) to Acquire Smaller Peer Exscientia in $688 Million Deal Read More »
